These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33071125)
41. MiR-219a-2-3p suppresses cell proliferation and promotes apoptosis by targeting MDM2/p53 in pituitary adenomas cells. Wang Y; Zhao J; Zhang C; Wang P; Huang C; Peng H Biosci Biotechnol Biochem; 2020 May; 84(5):911-918. PubMed ID: 31959058 [TBL] [Abstract][Full Text] [Related]
42. UNC119 is a binding partner of tumor suppressor Ras-association domain family 6 and induces apoptosis and cell cycle arrest by MDM2 and p53. Iwasa H; Sarkar A; Shimizu T; Sawada T; Hossain S; Xu X; Maruyama J; Arimoto-Matsuzaki K; Withanage K; Nakagawa K; Kurihara H; Kuroyanagi H; Hata Y Cancer Sci; 2018 Sep; 109(9):2767-2780. PubMed ID: 29931788 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-26a targets the mdm2/p53 loop directly in response to liver regeneration. Zhou J; Li Z; Huang Y; Ju W; Wang D; Zhu X; He X Int J Mol Med; 2019 Oct; 44(4):1505-1514. PubMed ID: 31364731 [TBL] [Abstract][Full Text] [Related]
44. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway. Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838 [TBL] [Abstract][Full Text] [Related]
45. Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. Salem MM; Shalbaf M; Gibbons NC; Chavan B; Thornton JM; Schallreuter KU FASEB J; 2009 Nov; 23(11):3790-807. PubMed ID: 19641144 [TBL] [Abstract][Full Text] [Related]
46. [mRNA expression levels of p53 and DNA damage and repair genes in peripheral blood lymphocytes of benzene-exposed workers]. Ye R; Pan JC; Cao JZ; Guan JR; Xie XM; Yu AX; Wu L; He YL; Xia ZL Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Apr; 26(4):219-22. PubMed ID: 18724895 [TBL] [Abstract][Full Text] [Related]
47. Mouse double minute homologue 2 (MDM2) downregulation by miR-661 impairs human endometrial epithelial cell adhesive capacity. Winship A; Ton A; Van Sinderen M; Menkhorst E; Rainczuk K; Griffiths M; Cuman C; Dimitriadis E Reprod Fertil Dev; 2018 Mar; 30(3):477-486. PubMed ID: 28847363 [TBL] [Abstract][Full Text] [Related]
48. CCAT2 contributes to hepatocellular carcinoma progression via inhibiting miR-145 maturation to induce MDM2 expression. Niu C; Wang L; Ye W; Guo S; Bao X; Wang Y; Xia Z; Chen R; Liu C; Lin X; Huang X J Cell Physiol; 2020 Sep; 235(9):6307-6320. PubMed ID: 32037568 [TBL] [Abstract][Full Text] [Related]
49. The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. Simerzin A; Zorde-Khvalevsky E; Rivkin M; Adar R; Zucman-Rossi J; Couchy G; Roskams T; Govaere O; Oren M; Giladi H; Galun E Hepatology; 2016 Nov; 64(5):1623-1636. PubMed ID: 27302319 [TBL] [Abstract][Full Text] [Related]
50. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347 [TBL] [Abstract][Full Text] [Related]
51. The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity. Pant V; Xiong S; Jackson JG; Post SM; Abbas HA; Quintás-Cardama A; Hamir AN; Lozano G Genes Dev; 2013 Sep; 27(17):1857-67. PubMed ID: 23973961 [TBL] [Abstract][Full Text] [Related]
52. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662 [TBL] [Abstract][Full Text] [Related]
53. Primate-specific miR-944 activates p53-dependent tumor suppression in human colorectal cancers. Kim YJ; Lee JH; Jin S; Kim JH; Kim SH Cancer Lett; 2019 Jan; 440-441():168-179. PubMed ID: 30393117 [TBL] [Abstract][Full Text] [Related]
54. Threshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cells. Li CQ; Pang B; Kiziltepe T; Trudel LJ; Engelward BP; Dedon PC; Wogan GN Chem Res Toxicol; 2006 Mar; 19(3):399-406. PubMed ID: 16544944 [TBL] [Abstract][Full Text] [Related]
55. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366 [TBL] [Abstract][Full Text] [Related]
56. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954 [TBL] [Abstract][Full Text] [Related]
57. Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia. Merkel O; Asslaber D; Piñón JD; Egle A; Greil R Cell Cycle; 2010 Jul; 9(14):2764-8. PubMed ID: 20581456 [TBL] [Abstract][Full Text] [Related]
58. LncRNA UCA1 protects cardiomyocytes against hypoxia/reoxygenation induced apoptosis through inhibiting miR-143/MDM2/p53 axis. Wang QS; Zhou J; Li X Genomics; 2020 Jan; 112(1):574-580. PubMed ID: 30998966 [TBL] [Abstract][Full Text] [Related]
59. Mdm2 widens its repertoire. Coutts AS; La Thangue NB Cell Cycle; 2007 Apr; 6(7):827-9. PubMed ID: 17377491 [TBL] [Abstract][Full Text] [Related]
60. Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma. Zhu HQ; Zhang C; Guo ZY; Yang JM; Guo JH; Chen C; Yao QH; Liu F; Zhang QW; Gao FH Cancer Med; 2019 Sep; 8(11):5313-5326. PubMed ID: 31339234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]